Niersmann, C.* et al. Higher afamin concentrations are associated with higher fatty liver indices: Population-based KORA F4/FF4 study. Eur. J. Clin. Invest., DOI: 10.1111/eci.70095:e70095 (2025)
Fontes, A. ; Ramalho-Santos, J.* ; Zischka, H. & Azul, A.M.* Mushrooms on the plate: Trends towards NAFLD treatment, health improvement and sustainable diets. Eur. J. Clin. Invest., DOI: 10.1111/eci.13667:e13667 (2021)
Scherb, H. Sars-CoV-2 in Germany: Association between deaths and positive rate. Eur. J. Clin. Invest. 51:e13500 (2021)
Zhang, X.* et al. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. Eur. J. Clin. Invest.:e13479 (2020)
Zischka, H. & Schmitt, S.* Mitochondria are indispensable for liver cancer cell proliferation. Eur. J. Clin. Invest. 49, 24-24 (2019)
Degano, I.* et al. In-hospital acute coronary syndrome management in Europe: Efficacy-proven pharmacological treatment trends 2000-2010, and its impact on vital status at discharge. Eur. J. Clin. Invest. 48, 135-136 (2018)
Simoes, I.* et al. Effects of Western diet on liver mitochondrial function in the context of nonalcoholic fatty liver disease. Eur. J. Clin. Invest. 48, 52-52 (2018)
Zischka, H. Mitochondrial adaptation in steatosis. Eur. J. Clin. Invest. 48, 31-31 (2018)
Zischka, H. Mitochondrial toxicology: Rescuing mitochondria in Wilson disease avoids acute liver failure. Eur. J. Clin. Invest. 47, 17-17 (2017)
Zischka, H. Rescuing mitochondria in Wilson disease avoids acute liver failure. Eur. J. Clin. Invest. 46, 62 (2016)
Dullaart, R.P.* et al. Research update for articles published in EJCI in 2012. Eur. J. Clin. Invest. 44, 1010-1023 (2014)
Herder, C.* et al. TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events. Eur. J. Clin. Invest. 42, 329-337 (2012)